TY - JOUR
T1 - (C)onsumer focused (E)ducation on p(A)racetamol (S)ide (E)ffects, i(N)adequate (O)utcomes and (W)eaning (CEASE NOW) for individuals with low back pain
T2 - results of a feasibility study
AU - Patterson, Thomas
AU - Turner, Justin
AU - Gnjidic, Danijela
AU - Mintzes, Barbara
AU - Bennett, Carol
AU - Bywaters, Lisa
AU - Clavisi, Ornella
AU - Baysari, Melissa
AU - Ferreira, Manuela
AU - Beckenkamp, Paula
AU - Ferreira, Paulo
N1 - Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.
PY - 2022/11/24
Y1 - 2022/11/24
N2 - Objectives: To determine the feasibility of a patient-education booklet to support patients with low back pain (LBP) to reduce paracetamol intake. Design: Single group, repeated measures feasibility study. Setting: Community. Participants: Adults experiencing LBP of any kind and self-reporting consumption of paracetamol for LBP weekly for at least 1 month were invited to participate. Intervention: Participants received a patient-education booklet 1 week after the baseline measures were collected. The intervention was designed to change beliefs, increase knowledge and self-efficacy to deprescribe paracetamol for their LBP and create discussion with a health professional through the mechanisms of motivation, capacity and opportunity. Primary outcome measures: Feasibility of recruitment procedures, data collection and acceptability of the intervention. Secondary outcome measures: Changes in motivation, self-efficacy, opportunity to deprescribe paracetamol for their LBP, paracetamol usage and LBP clinical outcomes at baseline, 1-week and 1-month follow-up. Results: A total of 24 participants were recruited into the study within the timeframe of 3 months from study advertisement and all completed the study follow-up. There were no missing data for any outcome measure across all follow-up points, 22 (91.6%) participants were willing to participate in a future randomised control trial (RCT) and over 60% of participants responded positively to questions regarding acceptability of the patient-educational booklet. Overall, at the 1-month follow-up, approximately two thirds (15/24) of participants had an increase in motivation and self-efficacy scores and had discussed or intended to discuss their paracetamol use for LBP with a health professional. Conclusions: The results of this study demonstrate that the patient-education booklet is feasible to implement, and both the intervention and study design were well-received by participants. This study supports the undertaking an RCT to assess the effects of the patient-education booklet on deprescribing paracetamol in people with LBP.
AB - Objectives: To determine the feasibility of a patient-education booklet to support patients with low back pain (LBP) to reduce paracetamol intake. Design: Single group, repeated measures feasibility study. Setting: Community. Participants: Adults experiencing LBP of any kind and self-reporting consumption of paracetamol for LBP weekly for at least 1 month were invited to participate. Intervention: Participants received a patient-education booklet 1 week after the baseline measures were collected. The intervention was designed to change beliefs, increase knowledge and self-efficacy to deprescribe paracetamol for their LBP and create discussion with a health professional through the mechanisms of motivation, capacity and opportunity. Primary outcome measures: Feasibility of recruitment procedures, data collection and acceptability of the intervention. Secondary outcome measures: Changes in motivation, self-efficacy, opportunity to deprescribe paracetamol for their LBP, paracetamol usage and LBP clinical outcomes at baseline, 1-week and 1-month follow-up. Results: A total of 24 participants were recruited into the study within the timeframe of 3 months from study advertisement and all completed the study follow-up. There were no missing data for any outcome measure across all follow-up points, 22 (91.6%) participants were willing to participate in a future randomised control trial (RCT) and over 60% of participants responded positively to questions regarding acceptability of the patient-educational booklet. Overall, at the 1-month follow-up, approximately two thirds (15/24) of participants had an increase in motivation and self-efficacy scores and had discussed or intended to discuss their paracetamol use for LBP with a health professional. Conclusions: The results of this study demonstrate that the patient-education booklet is feasible to implement, and both the intervention and study design were well-received by participants. This study supports the undertaking an RCT to assess the effects of the patient-education booklet on deprescribing paracetamol in people with LBP.
UR - http://www.scopus.com/inward/record.url?scp=85142619081&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2022-068164
DO - 10.1136/bmjopen-2022-068164
M3 - Article
C2 - 36424116
AN - SCOPUS:85142619081
SN - 2044-6055
VL - 12
SP - 1
EP - 9
JO - BMJ Open
JF - BMJ Open
IS - 11
M1 - e068164
ER -